Back to top

Image: Bigstock

Find Great Stocks with this New Analyst Coverage Screener

Read MoreHide Full Article

The Nasdaq surged to start the week, with the S&P 500 and the Dow both up on Monday as well. Relative stagnation then followed during regular trading Tuesday, with the calm likely welcome amid what has been a wild few weeks of inflation-based volatility.  

Clearly, Wall Street will continue to watch prices, inflation, and the Fed’s reactions very closely as the U.S. economy booms. But the Nasdaq has snapped back above its 50-day moving average and the benchmark index is once again within around 1% of its records. And even if the central bank does raise rates, Wall Street will still likely be chasing returns in the low-yield environment.

The inflation concerns have also somewhat clouded what continues to be an impressive first quarter earnings season. More importantly, estimates for the second quarter keep on climbing, with overall S&P 500 earnings projected to come in well above the pre-pandemic period of FY19 (also read: Looking Ahead to Q2 Earnings Season).

Given the broader bullish backdrop, investors might want to add to their portfolios. One way to find potential winners is to search for companies that have landed new analyst coverage recently. And the reasoning is pretty straightforward…

 

New Analyst Coverage

Broker recommendations play their part no matter how investors feel about them. And we seemingly all take a look no matter what. Individual investors, large institutional portfolio managers, and everyone in between are likely pleased to see one of their stocks get an upgraded rating or a new analyst cover the company.

Investor interest can generate more analyst coverage. This helps explain why analysts jump on young, much-hyped and talked about tech companies. Then, as new coverage is initiated, the company and the stock become more visible, which in turn often leads to more demand potential and therefore the possibility of higher prices. 

Plus, analysts almost always initiate coverage with a positive recommendation. And the logic follows because why spend all the time and write a research report on a company not widely tracked only to say it’s not good?

When it comes to companies with little to no analyst coverage, one new recommendation can sometimes give portfolio managers the validation they need to build a position. And the more money they can invest, the more they can potentially influence prices.

The best way to use this information is to search for companies with analyst coverage that has increased over the last 4 weeks. We just look at the number of analyst recommendations today and compare it to the number of analyst recommendations 4 weeks ago.

The rule of thumb here is that an increase in coverage leans bullish and a decrease signals bearish behavior. It is also worth pointing out that, in general, the change in the average broker recommendation is a better indicator than the actual recommendation itself.

On top of that, it is typically more bullish if the increase went from none to one or if the coverage was minimal to begin with. (As the number of analysts climbs the addition of new coverage isn’t earth-shattering.) In the end, increased coverage is still better than decreased coverage, unless the coverage is heading in the wrong direction. 

Now let’s try this screen…

• Number of Broker Ratings now greater than the Number of Broker Ratings four weeks ago

(This shows stocks where new coverage has recently been added.)

• Average Broker Rating less than Average Broker Rating four weeks ago

(By 'less than', we mean 'better than' four weeks ago.)

• Prices greater than or equal to 5

(We’re applying all of the above parameters to stocks above $5 a share since many money managers won't even look at stocks under $5)

• Average Daily Volume greater than or equal to 100,000 shares

(If there's not enough volume, even individual investors won't want it).

Here are two of the 10 stocks that came through the screen this week…

Rambus, Inc. (RMBS - Free Report) - (from 2 analysts four weeks ago to 3)

Vanda Pharmaceuticals Inc. (VNDA - Free Report) - (from 2 analysts four weeks ago to 3)

Many screeners won't let you search for the number of analysts covering a stock, let alone comparing the amount of coverage they had weeks or even months ago. But you can with the Research Wizard. And you can backtest it all. Find out how to pick the right stocks right now by taking a free trial to the Research Wizard stock picking and backtesting program.

Click here to sign up for a free trial to the Research Wizard today.

Want more articles from this author? Scroll up to the top of this article and click the FOLLOW AUTHOR button to get an email each time a new article is published.

Disclosure: Officers, directors and/or employees of Zacks Investment Research may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material. An affiliated investment advisory firm may own or have sold short securities and/or hold long and/or short positions in options that are mentioned in this material.

Disclosure: Performance information for Zacks’ portfolios and strategies are available at: https://www.zacks.com/performance.

Zacks' Super Screen

It's hard to believe, even for us at Zacks. But from 2000-2020, while the market gained +6.6% per year, our top stock-picking strategy averaged +52.4% per year.

How has that screen done lately? From 2016-2020, it more than tripled the market's +103.9% gain with a soaring +381.1% return.

Free – See the Stocks It Turned Up for Today >>


See More Zacks Research for These Tickers


Normally $25 each - click below to receive one report FREE:


Rambus, Inc. (RMBS) - free report >>

Vanda Pharmaceuticals Inc. (VNDA) - free report >>

Published in